Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Minerva Pediatr ; 72(1): 30-36, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31621274

RESUMEN

BACKGROUND: Headache is one of the main complaints in pediatric neurology. Exogenous melatonin has been shown to be useful and safe in improving sleep-wake cycles and sleep quality in children. Tryptophan as well plays a key role in sleep regulation. So far, no studies tried to analyze the effects of a combination of both melatonin and tryptophan in treating chronic headache in children affected also by night-time awakenings. METHODS: Thirty-four children with a diagnosis of chronic headache (with or without sleep disorders) have been enrolled. The study was articulated in two steps: 1) each child was observed for one month without any intervention; 2) children have been then randomized into two groups: the "ME-group", which received the nutritional supplement melatonin for two months and the "MET-group", which received the nutritional supplements melatonin, tryptophan, and vitamin B6 for two months. RESULTS: In terms of changes in number of headache events, responders in the ME-group were 91.7% and those in the MET-group were 66.7% (P=0.113). In terms of changes in number of night awakenings, in the ME group, mean number at baseline, after 30 days, and after 60 days were 3.6±3.2, 3.2±3.5, and 2.7±3.4 (P=0.495). In the MET group, mean number of night awakenings was 7.4±8.1, 4.0±4.4, and 3.3±2.9 (P=0.041). CONCLUSIONS: Using either nutritional supplement for two months can help in decreasing the monthly number of headache episodes and night awakenings. The addition of tryptophan and vitamin B6 appears to have stronger influence on night awakenings reduction than melatonin only.


Asunto(s)
Suplementos Dietéticos , Cefaleas Primarias/tratamiento farmacológico , Melatonina/administración & dosificación , Trastornos del Sueño-Vigilia/tratamiento farmacológico , Triptófano/administración & dosificación , Vitamina B 6/administración & dosificación , Adolescente , Antidepresivos de Segunda Generación/administración & dosificación , Antioxidantes/administración & dosificación , Niño , Femenino , Cefaleas Primarias/complicaciones , Humanos , Italia , Masculino , Proyectos Piloto , Trastornos del Sueño-Vigilia/complicaciones , Complejo Vitamínico B/administración & dosificación
2.
Curr Pain Headache Rep ; 20(1): 4, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26700695

RESUMEN

Chronic daily headache (CDH) is a very important part of primary headache disorder, and it causes heavy socioeconomic burden. An increasing number of people are suffering from CDH, and there are many treatment choices for the different subtypes of CDH. However, the definite effect of these treatments, especially the non-pharmacologic treatments, is still unclear and controversial. Acupuncture, a key component of Traditional Chinese Medicine (TCM), has an over 2500-year history in China as an effective non-pharmacologic method for chronic pain, but the researches on CDH are limited. Varying stimulations and the acupoints can be chosen for different acupuncturists, and there are many primary and secondary assessments of the therapeutic effect. Although acupuncture has been shown to have potential effects on CDH, it requires much deeper researches on the optimized usage and underlying mechanisms.


Asunto(s)
Terapia por Acupuntura , Dolor Crónico/terapia , Cefaleas Primarias/terapia , Trastornos de Cefalalgia/terapia , Trastornos Migrañosos/terapia , Animales , Dolor Crónico/complicaciones , Trastornos de Cefalalgia/complicaciones , Cefaleas Primarias/complicaciones , Humanos , Trastornos Migrañosos/complicaciones , Resultado del Tratamiento
3.
Med Hypotheses ; 66(6): 1146-51, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16530980

RESUMEN

Primary headaches include migraine, tension, cluster headaches, paroxysmal hemicrania and miscellaneous headaches unassociated with structural lesions. A putative role of the retino-hypothalamic-pineal (RHP) axis in the pathophysiology of primary headaches is reviewed in terms of (1) retinal dysfunction, (2) hypothalamic dysfunction and human circadian desynchrony, (3) pineal melatonin dysfunction and (4) rostral limbic dysfunction mediating the human stress response. Unified RHP hypothesis is proposed, suggesting that an acute, periodic or chronic, circadian desynchrony and dysfunction of the whole or part of the RHP axis is implicated in the pathophysiology of primary headaches. Supportive evidence for the RHP hypothesis, including recent PET studies showing changes in dorsal pons, hypothalamus and rostral limbic structures, is presented.


Asunto(s)
Trastornos Cronobiológicos/fisiopatología , Cefaleas Primarias/fisiopatología , Hipotálamo/fisiopatología , Melatonina/metabolismo , Modelos Neurológicos , Glándula Pineal/fisiopatología , Células Ganglionares de la Retina , Animales , Trastornos Cronobiológicos/complicaciones , Ritmo Circadiano , Cefaleas Primarias/complicaciones , Humanos , Sistema Límbico/fisiopatología , Vías Nerviosas/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA